Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01B with or without concomitant ChAd63/MVA ME-TRAP malaria sporozoite challenge study
2014-001301-40Phase 2Terminated
- Sponsor
- University of Oxford
- Start
- Jul 2014
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of RTS,S, ChAd63 ME-TRAP and MVA ME-TRAP in Falciparum malaria (PF) and malaria (4 arms), sponsored by University of Oxford. Primary endpoint: Protective efficacy against malaria challenge. Started Jul 2014; status: terminated.
02
Drugs
RTS,SChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
Falciparum malaria (PF)malaria
Beyond the preview
Go deeper on 2014-001301-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001301-40.